Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
The British Journal of Surgery
|
September 15, 2023
Machine learning to predict outcomes following endovascular abdominal aortic aneurysm repair
Ben Li, Badr Aljabri, Raj Verma, et al.
JAMA Network Open
|
March 14, 2024
Machine Learning to Predict Outcomes of Endovascular Intervention for Patients With PAD
Ben Li, Blair E Warren, Naomi Eisenberg, et al.
The Canadian Journal of Cardiology
|
January 25, 2022
Leaflet Resection vs Preservation for Degenerative Mitral Regurgitation: Functional Outcomes and Mitral Stenosis at 12 Months in a Randomized Trial
Makoto Hibino, Arjun Pandey, Vincent Chan, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
September 29, 2023
Empagliflozin improves circulating vascular regenerative cell content in people without diabetes with risk factors for adverse cardiac remodeling
Ehab Bakbak, Subodh Verma, Aishwarya Krishnaraj, et al.
The Annals of Thoracic Surgery
|
July 2, 2022
Risk Factors for Postrepair Elevated Mitral Gradient: A Post-hoc Analysis of a Randomized Trial
Makoto Hibino, Arjun K Pandey, Vincent Chan, et al.
Journal of the American College of Cardiology
|
February 14, 2024
Vascular Regenerative Cell Deficiencies in South Asian Adults
Aishwarya Krishnaraj, Ehab Bakbak, Hwee Teoh, et al.
Circulation
|
January 27, 2025
SLICE-CEA CardioLink-8: A Randomized Trial of Evolocumab on Carotid Artery Atherosclerotic Plaque Characteristics in Asymptomatic High-Risk Carotid Stenosis
C David Mazer, Alan R Moody, Hwee Teoh, et al.
Cardiovascular Research
|
August 29, 2025
Vascular regenerative deficiencies in people with elevated lipoprotein(a): the Lp(a)-VRCE CardioLink-16 translational study
Michael Moroney, Jack H Casey, Hwee Teoh, et al.
Iscience
|
August 31, 2021
A randomized trial of icosapent ethyl in ambulatory patients with COVID-19
Andrew Kosmopoulos, Deepak L Bhatt, Gus Meglis, et al.
Circulation
|
November 6, 2022
Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial
Kim A Connelly, C David Mazer, Pankaj Puar, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
The British Journal of Surgery
|
September 15, 2023
Machine learning to predict outcomes following endovascular abdominal aortic aneurysm repair
Ben Li, Badr Aljabri, Raj Verma, et al.
JAMA Network Open
|
March 14, 2024
Machine Learning to Predict Outcomes of Endovascular Intervention for Patients With PAD
Ben Li, Blair E Warren, Naomi Eisenberg, et al.
The Canadian Journal of Cardiology
|
January 25, 2022
Leaflet Resection vs Preservation for Degenerative Mitral Regurgitation: Functional Outcomes and Mitral Stenosis at 12 Months in a Randomized Trial
Makoto Hibino, Arjun Pandey, Vincent Chan, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
September 29, 2023
Empagliflozin improves circulating vascular regenerative cell content in people without diabetes with risk factors for adverse cardiac remodeling
Ehab Bakbak, Subodh Verma, Aishwarya Krishnaraj, et al.
The Annals of Thoracic Surgery
|
July 2, 2022
Risk Factors for Postrepair Elevated Mitral Gradient: A Post-hoc Analysis of a Randomized Trial
Makoto Hibino, Arjun K Pandey, Vincent Chan, et al.
Journal of the American College of Cardiology
|
February 14, 2024
Vascular Regenerative Cell Deficiencies in South Asian Adults
Aishwarya Krishnaraj, Ehab Bakbak, Hwee Teoh, et al.
Circulation
|
January 27, 2025
SLICE-CEA CardioLink-8: A Randomized Trial of Evolocumab on Carotid Artery Atherosclerotic Plaque Characteristics in Asymptomatic High-Risk Carotid Stenosis
C David Mazer, Alan R Moody, Hwee Teoh, et al.
Cardiovascular Research
|
August 29, 2025
Vascular regenerative deficiencies in people with elevated lipoprotein(a): the Lp(a)-VRCE CardioLink-16 translational study
Michael Moroney, Jack H Casey, Hwee Teoh, et al.
Iscience
|
August 31, 2021
A randomized trial of icosapent ethyl in ambulatory patients with COVID-19
Andrew Kosmopoulos, Deepak L Bhatt, Gus Meglis, et al.
Circulation
|
November 6, 2022
Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial
Kim A Connelly, C David Mazer, Pankaj Puar, et al.
Page
of 10